TerminatedNot Applicable

CONNEQT Pulse Validation Study

Stopped: Unable to recruit intended patient population

United States41 participantsStarted 2023-08-21

Plain-language summary

The purpose of this study is to validate the accuracy of the CONNEQT Pulse blood pressure monitoring system for the measurement of blood pressure as compared to a gold standard, auscultatory sphygmomanometer in a pregnant population.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

All Groups: 1. Able to provide informed consent 2. Pregnant patient, beyond the first trimester (greater than 12 weeks of gestation) 3. 18 years of age, or older Normotensive: 1\. Systolic blood pressure \<140 mmHg (18,66 kPa) and diastolic blood pressure \<90 mmHg (12 kPa) Hypertensive: 1. Without proteinuria \>300 mg in 24 h; and 2. With systolic blood pressure ≥140 mmHg (18,66 kPa) or diastolic blood pressure ≥ 90 mmHg (12 kPa) Pre-Eclampsia: 1. With proteinuria \>300 mg in 24 h; and 2. With systolic blood pressure ≥140 mmHg (18,66 kPa) or diastolic blood pressure ≥ 90 mmHg (12,00 kPa)

What they're measuring

Comparison of reference auscultatory blood pressure readings to CONNEQT Pulse blood pressure readings.

Timeframe: Up to 60 minutes

Trial details

NCT IDNCT06002971

SponsorMount Carmel Health System

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06-03

View on ClinicalTrials.gov More Pregnancy Related trials